Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Dermicus platform has been implemented at scale in Sweden and the UK. Clinical studies during pilot phases demonstrated improved patient care quality. In the NHS Isle of Wight implementation, cancer waiting times were reduced from an average of 26 days to just 0.6 days. The company’s solutions are CE-certified medical devices and have passed major compliance assessments including NHSX DTAC in the UK. Dermicus has delivered over 15,000 consultations with more than 60,000 images maintained as of late 2018; these numbers have likely grown since then. Dermicus was shortlisted for the HSJ Awards – Primary Care Innovation of the Year.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermicus.